8-K: U.S. Physical Therapy Reports Record Patient Volumes and Strong Revenue Growth in 2023

U.S. Physical Therapy achieved record patient volumes and a 10.6% increase in physical therapy revenue in 2023, despite challenges from Medicare rate reductions and a tight labor market.

Summary

• U.S. Physical Therapy reported record patient volumes in 2023, reaching 30 visits per clinic per day.
• Total visits exceeded 5 million for the year, an 11.6% increase from 2022.
• Physical therapy revenues increased by more than $50 million, a 10.6% rise year-over-year.
• The company's industrial injury prevention (IIP) business saw a 9.7% revenue growth in the fourth quarter, with operating income up almost 30% over the prior year.
• Adjusted EBITDA for the fourth quarter was $19 million, up from $17.9 million in the same period last year.
• Operating results were $0.59 per share in the fourth quarter of 2023, compared to $0.58 in the fourth quarter of 2022.
• Total company revenues increased 9.6% in the fourth quarter, reaching $154.8 million.
• The company added 46 clinics via acquisitions and de novos in 2023, resulting in a net increase of 31 clinics after closures.
• A secondary offering in May 2023 provided cash for growth opportunities.
• The company's net rate was $103.68 in the fourth quarter of 2023, a sequential increase from $102.37 in the third quarter, but down from $104.28 in the fourth quarter of 2022 due to Medicare rate reductions.
• The company expects 2024 EBITDA to be in the range of $80 to $85 million, despite a 3.5% Medicare rate reduction that will reduce revenue by $6 million and EBITDA by $5.3 million.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to record patient volumes, strong revenue growth, and successful cost management. The company is also optimistic about future growth and has a strong financial position. However, the negative impact of Medicare rate reductions and weather events temper the overall sentiment.

Positives

• The company achieved record patient volumes in 2023, demonstrating strong demand for its services.
• Physical therapy revenues increased by 10.6% year-over-year, indicating solid growth.
• The industrial injury prevention business showed significant growth in the fourth quarter, with a 9.7% increase in revenue and a nearly 30% increase in operating income.
• Operating costs per visit decreased for the full year, showing improved efficiency.
• The company successfully renegotiated a significant number of payor contracts in 2023, which is positively impacting rates.
• The company has a strong balance sheet with $120 million of excess cash available for growth initiatives.
• The company's debt is at a favorable fixed rate of 4.7% due to a swap agreement.
• The company increased its quarterly dividend rate by one cent for the first quarter of 2024.
• The company expects EBITDA growth in 2024, despite Medicare rate reductions.

Negatives

• The company experienced a 2% Medicare rate reduction in 2023, which negatively impacted revenue.
• The net rate per visit decreased compared to the fourth quarter of 2022 due to Medicare rate reductions.
• The company faces a 3.5% Medicare rate reduction in 2024, which will reduce revenue by $6 million and EBITDA by $5.3 million.
• The company experienced some weather-related challenges in January 2024, which may impact first-quarter results.

Risks

• The company faces ongoing challenges from Medicare rate reductions, which will continue to impact revenue and profitability.
• The company operates in a competitive labor market, which could impact its ability to attract and retain therapists.
• The company's growth is dependent on its ability to successfully integrate acquisitions and manage new clinics.
• The company's financial performance is subject to changes in healthcare regulations and payor contracts.
• The company's future performance is subject to the timing and success of acquisitions.

Future Outlook

The company expects 2024 EBITDA to be in the range of $80 to $85 million, despite a 3.5% Medicare rate reduction. The company anticipates growth from rate negotiations, increased volumes, and acquisitions. The company expects to close several acquisitions by roughly the middle of 2024.

Management Comments

• The past year was one of persistently high demand for our physical therapy services.
• Our clinical teams did an exemplary job caring for our patients, which in turn creates additional demand from happy customers.
• We renegotiated a significant number of payor contracts in 2023, which is bearing fruit for us in and across our commercial contract base.
• The partners we added in 2023 are ahead of plan and doing terrific.
• We have tremendous confidence in our team to produce EBITDA growth in 2024.
• We feel very good about growth in 2024, and we look forward to producing strong results for all of our stakeholders in 2024.

Industry Context

The company's performance reflects the continued demand for physical therapy services and the importance of managing costs and payor relationships in the healthcare industry. The company is actively working to mitigate the impact of Medicare rate reductions through contract negotiations and operational efficiencies. The company is also expanding its presence through acquisitions and de novo clinics.

Comparison to Industry Standards

• The company's record patient volumes of 30 visits per clinic per day is a strong performance metric compared to industry averages.
• The company's ability to increase revenue by 10.6% in physical therapy demonstrates strong market demand and effective management.
• The company's focus on renegotiating payor contracts and improving operational efficiencies is a common strategy in the healthcare industry to mitigate the impact of rate reductions.
• The company's growth through acquisitions is a common strategy in the physical therapy industry to expand market share and geographic reach.
• The company's ability to maintain a favorable debt rate of 4.7% is a positive indicator of its financial management.

Stakeholder Impact

• Shareholders will benefit from the company's strong financial performance and increased dividend.
• Employees will benefit from the company's growth and stability.
• Patients will benefit from the company's commitment to providing high-quality care.
• Payors will benefit from the company's focus on cost-effective care.
• Acquired partners will benefit from the company's resources and expertise.

Next Steps

• The company will continue to focus on driving additional volume to its facilities.
• The company will continue to renegotiate payor contracts to improve rates.
• The company will continue to pursue acquisitions to expand its market presence.
• The company will continue to manage costs and improve operational efficiencies.
• The company expects to close several acquisitions by roughly the middle of 2024.

Key Dates

Keywords

physical therapy, EBITDA, revenue, patient volume, acquisitions, Medicare, industrial injury prevention, payor contracts, clinic growth, operating costs